Tracks the sales and growth of 1800 products each month and provides insight into the global performance of all the leading pharmaceutical companies, ahead of quarterly results.
Tracks the sales and growth of 1800 products each month and provides insight into the global performance of all the leading pharmaceutical companies, ahead of quarterly results.
- Covers the world’s key retail pharmacy markets with figures collected directly from the wholesales for a truly independent measure
- Total sales for each product in each region are given with details of growth to provide a greater understanding of the market place
- Covers the leading products for all the ‘large-cap’ companies plus the majority of ‘mid-cap’ and larger ‘speciality’ companies including generic manufacturers
- Shows the key products and their competition for the leading therapeutic categories
- Delivered each month to provide access to sales figures between quarterly results
Covers1800 internationally consolidated products
Key products for the top 70 pharmaceutical and generic companies Key products for the top 50 therapeutic areas Retail sales in 13 countries consolidated into three regions:
- North America (Canada and USA*)
- Europe (Germany, Italy, UK, France, Spain)
- Other (Japan**, Mexico, Argentina, Brazil, Australia/NZ)
Including:
Sales in US dollars and Euros
Sales at a constant exchange rate
Growth broken down by innovation, volume, price and exchange rates
Delivery
Twelve months of data
A rolling 12 months of data is included for trending and quick analysis. An extra 12 months of data is also available to create 2 years of back data.
More about this offering
